Dose Finding and Early Efficacy Study of Erlotinib in Treatment of Chronic Hepatitis C Virus infection - proof of Concept Study
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Erlotinib (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 16 Oct 2013 New source identified and integrated: European Clinical Trials Database record.
- 01 May 2013 New trial record